Ahu Demir analyst

Currently out of the existing stock ratings of Ahu Demir, 2 are a HOLD (12.5%), 14 are a BUY (87.5%).

Ahu Demir

Work Performance Price Targets & Ratings Chart

Analyst Ahu Demir, carries an average stock price target met ratio of 50% that have a potential upside of 46% achieved within 114 days. Previously, Ahu Demir worked at LADENBURG, NOBLE CAPITAL.

Ahu Demir’s has documented 30 price targets and ratings displayed on 11 stocks. The coverage was on Healthcare, Basic Materials, Technology sectors.

Most recent stock forecast was given on EVAX, Evaxion Biotech AS at 02-Apr-2024.

Wall Street Analyst Ahu Demir

Analyst best performing recommendations are on ONTX (ONCONOVA THERAPEUTICS).
The best stock recommendation documented was for ONTX (ONCONOVA THERAPEUTICS) at 12/22/2020. The price target of $6.9 was fulfilled within 1 day with a profit of $0.47 (7.31%) receiving and performance score of 73.09.

Average potential price target upside

AYLA Ayala Pharmaceuticals  ONTX Onconova Therapeutics EVAX Evaxion Biotech AS DYAI Dyadic International TXMD TherapeuticsMD AA Alcoa Corp AADI Aadi Bioscience ECOR Electrocore LLC IMCR Immunocore Holdings Ltd ON ON Semiconductor PK Park Hotels & Resorts

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 31-Oct-2022

$16

3 years 8 months 25 days ago
(31-Oct-2022)

0/1 (0%)

$12 (300.00%)

Buy Since 07-Dec-2020

$0.55

$0.05 (10.00%)

3 years 9 months 6 days ago
(20-Oct-2022)

2/2 (100%)

$-0.13 (-19.12%)

50

Buy Since 21-Dec-2021

$18

3 years 11 months 10 days ago
(16-Aug-2022)

0/2 (0%)

$9.25 (105.71%)

Buy Since 10-Jun-2020

$6

4 years 3 months 26 days ago
(30-Mar-2022)

0/2 (0%)

$2.05 (51.90%)

Buy Since 21-Dec-2021

$12

$11.5 (2300.00%)

$18

4 years 3 months 26 days ago
(30-Mar-2022)

0/3 (0%)

$8 (200.00%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Ahu Demir?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?